CLXT Calyxt

Calyxt Announces Launch of Proposed Follow-On Offering

Regulatory News:

Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) and Calyxt, Inc. (NASDAQ: CLXT) announced today that Calyxt has commenced a follow-on public offering of 3,050,000 shares of Calyxt’s common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (SEC). In connection with the offering, Calyxt intends to grant the underwriters a 30-day option to purchase up to an additional 457,500 shares of Calyxt’s common stock.

Calyxt is a consumer-centric food- and agriculture-focused company. Cellectis owns approximately 79.1% of Calyxt’s outstanding shares of common stock.

Citigroup, Goldman Sachs & Co. LLC and Jefferies are acting as book-running managers for the proposed offering, Wells Fargo Securities is acting as lead manager and BMO Capital Markets is acting as co-manager.

This offering will be made only by means of a prospectus (included in the registration statement on Form S-1). A copy of the preliminary prospectus may be obtained from Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (800) 831-9146; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526, or by facsimile at (212) 902-9316, or by email at [email protected]; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 547-6340, or by e-mail at [email protected].

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. The registration statement is available at www.sec.gov. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

EN
15/05/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Calyxt

Calyxt Inc: 1 director

A director at Calyxt Inc bought 20,000 shares at 3.206USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Fourth Quarter and Full Year 2020 Financial Results Con...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 4, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome and Chief Financial Officer Bill Koschak will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome, Chief Financial Officer Bill Koschak, Chief Business Development and Supply Chain Officer Manoj Sahoo and Senior Vice President of Sales & Marketing Keith Blanks will host the conference call, followed by a question a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch